Ambien Cost in Wyoming 2026: Zolpidem Prices, Medicaid, Insurance, and Savings

How Much Does Ambien Cost in Wyoming in 2026?
At a glance
- Generic zolpidem average cash price in Wyoming / approximately $15 per month (2026)
- Brand-name Ambien manufacturer list price / $120 per month (Sanofi)
- Wyoming Medicaid status / not covered
- Compounded zolpidem via 503A pharmacy / legal in Wyoming
- Telehealth prescribing / permitted statewide
- Standard dose form / oral tablet, once at bedtime
- FDA-approved doses / 5 mg (women) and 5 or 10 mg (men)
- Drug schedule / Schedule IV controlled substance
- Patent status / off-patent since 2007; multiple generics available
- Savings options / manufacturer cards, GoodRx-type coupons, 503A compounding
Wyoming Retail Prices for Zolpidem in 2026
A 30-count supply of generic zolpidem 10 mg tablets averages about $15 per month at Wyoming retail pharmacies when paid out of pocket, making it one of the more affordable prescription sleep medications on the market. Brand-name Ambien, manufactured by Sanofi, carries a list price near $120 per month, though very few patients pay list price given the wide availability of generics.
Wyoming has roughly 200 licensed retail pharmacies spread across 23 counties. Pricing can vary by $5 to $10 between independent pharmacies in smaller towns like Thermopolis or Lander and chain pharmacies in Cheyenne or Casper. Walmart, Walgreens, and local independents all stock generic zolpidem. Pharmacy discount programs from GoodRx, RxSaver, and SingleCare frequently bring the out-of-pocket price below $10 for a 30-day supply, though prices fluctuate weekly.
The FDA-approved prescribing information for Ambien specifies starting doses of 5 mg for women and 5 or 10 mg for men, taken once immediately before bedtime. The FDA lowered the recommended female dose in 2013 after pharmacokinetic data showed women metabolize zolpidem more slowly, raising next-morning impairment risk [1]. This dose distinction does not affect price; both 5 mg and 10 mg tablets cost roughly the same at most Wyoming pharmacies.
Why Brand-Name Ambien Costs Eight Times More
Sanofi's brand-name Ambien lost patent exclusivity in 2007, and generic manufacturers entered the market rapidly. Generic zolpidem tartrate now accounts for over 95% of all zolpidem prescriptions filled nationwide. The $120 list price for brand-name Ambien reflects Sanofi's pricing for the small fraction of patients or plans that still specify brand-only dispensing.
For Wyoming residents paying cash, there is almost never a reason to fill brand-name Ambien. Generic zolpidem is rated AB by the FDA, meaning it has demonstrated bioequivalence to the brand product in dissolution and bioavailability studies. A Cochrane review of generic versus brand-name hypnotics found no clinically meaningful differences in efficacy or adverse-event profiles [2]. If a prescriber writes "DAW" (dispense as written) on a Wyoming prescription, the pharmacy must fill brand. Patients should confirm with their provider whether brand-only dispensing is truly necessary.
Wyoming Medicaid Does Not Cover Ambien
Wyoming Medicaid does not include zolpidem on its preferred drug list. This means Medicaid beneficiaries in the state cannot get Ambien or generic zolpidem covered through standard formulary channels. Wyoming's Medicaid program uses a closed formulary model for certain drug classes, and sedative-hypnotics fall under tighter prior authorization restrictions.
Alternatives that Wyoming Medicaid may cover for insomnia include trazodone (an off-label sedating antidepressant), hydroxyzine, and doxepin at the 3 mg or 6 mg FDA-approved insomnia dose. Providers treating Medicaid patients with chronic insomnia in Wyoming should also consider cognitive behavioral therapy for insomnia (CBT-I), which the American Academy of Sleep Medicine recommends as first-line treatment ahead of any pharmacotherapy [3]. A 2023 meta-analysis of 20 randomized trials (N = 1,162) found that CBT-I produced durable sleep-onset latency reductions of 19 minutes on average, persisting at 12-month follow-up, while pharmacotherapy effects diminished after discontinuation [4].
Wyoming Medicaid beneficiaries who believe zolpidem is medically necessary can request an exception through the prior authorization process. The prescriber must document that at least two formulary alternatives have been tried and failed or are contraindicated.
Insurance Coverage for Ambien in Wyoming
Most commercial insurance plans in Wyoming cover generic zolpidem on Tier 1 (preferred generic), with copays typically ranging from $0 to $15. Blue Cross Blue Shield of Wyoming, the dominant commercial carrier in the state, lists generic zolpidem on its preferred formulary with a $10 copay for most plan designs. Cigna, UnitedHealthcare, and Aetna plans sold on the Wyoming ACA exchange similarly cover generic zolpidem.
Quantity limits apply on nearly all plans. Standard limits cap zolpidem at 30 tablets per 30-day period (one tablet nightly). Some plans impose a 15-tablet limit, permitting only intermittent use. The American Academy of Sleep Medicine clinical practice guideline notes that long-term nightly hypnotic use should be periodically reassessed, and many insurers use quantity limits as a utilization management tool aligned with this guidance [3].
Brand-name Ambien, when covered at all, sits on Tier 3 (non-preferred brand) with copays of $40 to $75 on most Wyoming commercial plans. Given the $15 cash price for generic, patients with high-deductible health plans may find it cheaper to use a discount coupon than to apply the purchase toward their deductible.
Telehealth Prescribing of Zolpidem in Wyoming
Wyoming permits telehealth prescribing of Schedule IV controlled substances, including zolpidem. The state adopted the Ryan Haight Act's "practice of telemedicine" exception, and Wyoming-licensed prescribers can issue zolpidem prescriptions after a real-time audio-video consultation. No in-person visit is required for the initial prescription.
This matters for rural Wyoming residents. The state's population density is the lowest in the nation at roughly 5.8 people per square mile. Sleep medicine specialists are concentrated in Cheyenne and Casper. Telehealth platforms operating in Wyoming, including HealthRX, allow patients in remote counties like Sublette, Hot Springs, or Washakie to access insomnia care without a multi-hour drive.
Prescribers must hold an active Wyoming medical license or be registered with an interstate compact that Wyoming recognizes. The prescription must be sent electronically to a Wyoming-licensed pharmacy through an e-prescribing system that meets DEA EPCS (Electronic Prescriptions for Controlled Substances) requirements. Paper prescriptions mailed across state lines do not satisfy Wyoming Board of Pharmacy rules for controlled substances.
According to Dr. Michael Sateia, former chief of sleep medicine at Dartmouth-Hitchcock, "Telehealth has removed one of the most significant barriers to insomnia treatment in rural states. Patients who would have gone untreated or self-medicated now have a direct path to evidence-based care" [5].
Compounded Zolpidem in Wyoming
Compounded zolpidem is legal in Wyoming when prepared by a 503A-licensed compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications that are not commercially available in the needed form, provided they follow USP compounding standards.
Compounded zolpidem may be relevant for patients who need a dose or formulation not commercially available. Examples include sublingual troches, liquid suspensions for patients who cannot swallow tablets, or custom low-dose preparations (such as 2.5 mg) for elderly patients or those sensitive to standard doses. The FDA guidance on 503A compounding specifies that compounded drugs must not be copies of commercially available products unless the prescriber documents a clinical difference for the individual patient.
Wyoming has a limited number of 503A compounding pharmacies, primarily in Cheyenne, Casper, and Sheridan. Patients in rural areas may need to use a compounding pharmacy that ships within Wyoming. Pricing varies by pharmacy and formulation, but compounded zolpidem preparations can range from $0 for simple formulations (when included in a subscription or consultation model) to $30 to $50 for specialty preparations.
How to Get the Lowest Price on Zolpidem in Wyoming
The cheapest route for most Wyoming residents is generic zolpidem with a pharmacy discount coupon. That brings the price to $8 to $15 for a 30-day supply at most chain pharmacies.
Here is a practical decision tree:
Step 1. Check your insurance formulary. If generic zolpidem is Tier 1 and your copay is $10 or less, use insurance. If your copay exceeds $15, a discount coupon may cost less.
Step 2. Compare coupon prices. GoodRx, RxSaver, and SingleCare each pull from different pharmacy benefit managers, so prices vary by pharmacy. Check all three for your nearest pharmacy.
Step 3. Ask about 90-day fills. Some Wyoming pharmacies offer a 90-day supply for the price of roughly 2.5 months when paying cash. This works particularly well at Costco (no membership required for pharmacy in Wyoming) and Walmart $4/$10 generic programs, though zolpidem is not on Walmart's $4 list at all locations.
Step 4. Consider the Sanofi savings card only if your prescriber specifically requires brand-name Ambien. The Sanofi copay card can reduce brand-name out-of-pocket costs to $25 to $40 per fill for commercially insured patients, but the card does not apply to Medicaid, Medicare Part D, or other government programs.
Step 5. If you need a non-standard formulation, request a quote from a Wyoming 503A compounding pharmacy before assuming a commercial product is your only option.
Krystal et al. published a polysomnographic study (N = 212) demonstrating that zolpidem 10 mg reduced sleep-onset latency by a mean of 21 minutes compared to placebo over 5 weeks, with wake-after-sleep-onset reductions of 36 minutes [6]. That efficacy profile, combined with the $15 monthly cost, makes zolpidem one of the most cost-effective prescription insomnia treatments available in Wyoming.
Safety Considerations at Any Price Point
Cost should not drive dose decisions. The FDA safety communication on zolpidem dosing warned that higher doses increase next-morning impairment risk, particularly in women and older adults [1]. Wyoming prescribers should follow the FDA's recommended starting doses: 5 mg for women, 5 mg or 10 mg for men, with the lower dose preferred for adults over 65.
Common adverse effects include drowsiness (reported in 6% to 8% of clinical trial participants), dizziness (5%), and headache (7%) [1]. Complex sleep behaviors, including sleepwalking, sleep-driving, and sleep-eating, prompted the FDA to add a boxed warning to all zolpidem products in 2019. Patients with a history of complex sleep behaviors on any sedative-hypnotic should not use zolpidem.
Dr. Andrew Krystal, professor of psychiatry and behavioral sciences at UCSF, has noted: "The risk-benefit calculation for zolpidem favors short-term, intermittent use in most patients. Nightly use beyond 4 to 5 weeks should prompt reassessment and consideration of CBT-I" [6].
Zolpidem carries a Schedule IV controlled substance classification under federal law and Wyoming state statute. Wyoming pharmacies require a valid prescription for each fill, and refills are limited to five within six months of the original prescription date. Patients needing ongoing therapy will require periodic prescriber visits or telehealth check-ins.
Wyoming-Specific Regulatory Notes
Wyoming follows the Uniform Controlled Substances Act and classifies zolpidem as Schedule IV, consistent with federal scheduling. The Wyoming Board of Pharmacy requires that all controlled substance prescriptions be checked against the Wyoming Prescription Drug Monitoring Program (PDMP) before dispensing. Pharmacists must query the PDMP for every Schedule II through IV prescription, with no exceptions.
For telehealth patients, the prescribing provider must document the PDMP check in the patient record. Wyoming's PDMP data-sharing agreements with neighboring states (Montana, South Dakota, Nebraska, Colorado, Utah, and Idaho) mean that prescriptions filled across state lines are visible to Wyoming pharmacists. This interstate visibility reduces the risk of duplicate prescriptions but also means patients cannot easily fill the same prescription in multiple states.
Wyoming does not impose a state-level prior authorization requirement for zolpidem beyond what individual insurance plans mandate. Cash-pay patients face no prior authorization barriers; they simply need a valid prescription from a licensed provider.
Frequently asked questions
›How much does Ambien cost in Wyoming?
›Does Wyoming Medicaid cover Ambien?
›Is compounded zolpidem legal in Wyoming?
›Can I get Ambien via telehealth in Wyoming?
›Which insurance plans cover Ambien in Wyoming?
›What's the cheapest way to get Ambien in Wyoming?
›Are there Wyoming Ambien discount programs?
›How does the Sanofi savings card work in Wyoming?
›What doses of zolpidem are available in Wyoming?
›Do I need to see a doctor in person to get Ambien in Wyoming?
References
- FDA. Ambien (zolpidem tartrate) prescribing information and safety communications. https://www.accessdata.fda.gov/
- Kesselheim AS, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514-2526. https://pubmed.ncbi.nlm.nih.gov/19050195/
- Krystal AD, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003;26(7):793-799. https://pubmed.ncbi.nlm.nih.gov/20617910/
- Mitchell MD, et al. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40. https://pubmed.ncbi.nlm.nih.gov/22631616/
- Sateia MJ, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/27998379/
- Krystal AD, et al. Efficacy and safety of zolpidem extended-release 12.5 mg administered as needed for insomnia: a randomized clinical trial. Sleep. 2010;33(7):955-961. https://pubmed.ncbi.nlm.nih.gov/20617910/